Home  >   Products   >   Hypertension Essentials iPhone App

Hypertension Essentials iPhone App

  • Author(s):

  • Norman M. Kaplan, MD, Professor, University of Texas Southwestern Medical Center, Dallas, Texas
    Michael A. Weber, MD, Professor and Associate Dean, SUNY Downstate College of Medicine, Brooklyn, New York

  • Details:

  • ISBN-13: 9780763798710

    Mobile     © 2010

  • Price:

  • $24.99

Recommend this Title»

Overview

The World's Leading Experts Provide all the 'Essentials' Needed to Manage Hypertension Patients in the Office, on the Ward and in the Intensive Care Unit, now conveniently available for your iPhone, iTouch or iPad.1

Hypertension affects hundreds of millions of individuals worldwide, including 60% of those over the age of 60. Proper treatment reduces by 30% the incidence and fatality from coronary heart disease, heart failure, stroke, and kidney disease. The Hypertension Essentials iPhone App is a current, concise, and practical step-by-step tool to the diagnosis, evaluation, and treatment of hypertension. More than 50 clinical trials, common management pitfalls, and cardiovascular risk reduction measures are also described.

1iPad is supported through iPhone-compatibility mode.

Table of ContentsShow

 

 

 

SECTION 1. DIAGNOSIS, EVALUATION, AND TREATMENT OF HYPERTENSION

1. OVERVIEW OF HYPERTENSION

  • Defi nition
  • Incidence
  • Natural History
  • Etiology
  • Pathophysiology
  • Approach to Diagnosis and Treatment
  • Effect of Treatment
  • Awareness, Treatment, and Control
  • Prevention

 2. EVALUATION OF HYPERTENSION

 

Step 1. Confi rm and Stage Hypertension

  • Proper Blood Pressure Measurement
  • Technique
  • Exclude White-Coat Hypertension and
  • Pseudohypertension
  • Staging Blood Pressure
  • Ambulatory Blood Pressure Monitoring

 

Step 2. Evaluate the Patient Clinically

  • Overview
  • Assessment of Target Organ Damage
  • Detection of Secondary Hypertension

 

Step 3. Risk Stratification

  • Overview
  • Low-Risk (Group A)
  • Intermediate-Risk (Group B)
  • High-Risk (Group C)

 

Step 4. Initiate Treatment and Optimize

  • Compliance
  • Blood Pressure Goals
  • Approach to Treatment
  • Therapeutic Lifestyle Changes
  • Drug Therapy
  • Optimizing Patient Compliance  

3. TREATMENT OF ESSENTIAL

HYPERTENSION

 

4. ANTIHYPERTENSIVE DRUG

CLASSES: MECHANISM OF ACTION AND

SELECTED FEATURES

 

Diuretics and Potassium Sparers

  • Mechanism of Action
  • Major Use
  • Dosage and Administration
  • Frequent or Serious Adverse Effects
  • Aldosterone Blockers

ACE Inhibitors

  • Mechanism of Action
  • Major Uses
  • Administration and Monitoring
  • Frequent or Severe Adverse Effects
  • Angiotensin II Receptor Blockers
  • Mechanism of Action
  • Clinical Effects
  • Administration and Side Effects

Direct Renin Inhibitors (DRI)

  • β-Blockers
  • Mechanism of Action
  • Properties
  • Major Uses
  • Frequency of Serious Side Effects

Vasodilating β-Blockers

  • Calcium Channel Blockers
  • Mechanism of Action
  • Major Uses
  • Frequency of Serious Adverse Effects

α-1 Adrenergic Blockers

  • Central α-Adrenergic Agents
  • Direct Vasodilators
  • Choices of Therapy

SECTION 2. OTHER TOPICS IN HYPERTENSION

 

5. HYPERTENSIVE CRISIS

6. RESISTANT HYPERTENSION

7. IDENTIFIABLE (SECONDARY)HYPERTENSION

 

Clinical Trials

  • ACCOMPLISH
  • ALLHAT
  • ANBP2
  • ASCOT
  • CONVINCE
  • DORADO
  • EXFORGE-HCT
  • HYVET
  • INVEST
  • LIFE
  • ONTARGET
  • TEKTURNA HCT
  • VALUE

REFERENCES

 

INDEX


Back to top

About the Author(s)Show

Norman M. Kaplan, MD-Professor, University of Texas Southwestern Medical Center, Dallas, Texas

Dr. Kaplan is Clinical Professor of Internal Medicine at the University of Texas Southwestern Medical Center at Dallas where he has been on the faculty for more than forty years. For the last twenty, his teaching, writing and research have focused primarily upon clinical aspects of hypertension. He has lectured extensively and contributed over 500 papers to the medical literature. The ninth edition of his textbook, Kaplan’s Clinical Hypertension, was published in 2006. He was a member of the third, fourth, fifth, and sixth Joint National Committees on Detection, Evaluation and Treatment of High Blood Pressure. He has been made a Master of the American College of Physicians, given the Lifetime Achievement Award by the American Heart Association’s Council for High Blood Pressure Research, and received the Stevo Julius Award for Leadership in Medical Communication presented by the International Society of Hypertension. He served on the Executive Committees of the American Society of Hypertension and the AHA Council for High Blood Pressure Research. He is involved as either editor or reviewer with most of the journals which publish papers in the hypertension arena.

Michael A. Weber, MD-Professor and Associate Dean, SUNY Downstate College of Medicine, Brooklyn, New York

Back to top

Related Titles

Tarascon Pharmacopoeia iPhone & iPad App

RELATED SUBJECTS

Cardiology

STAY CONNECTED

Sign up to receive updates, special offers, and promotions by email.